ChitogenX Inc. (CSE:CHGX)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
Jun 10, 2025, 9:04 AM EDT
ChitogenX Company Description
ChitogenX Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of orthopaedic and sports medicine surgeries in Canada.
It develops Ortho-R, a biopolymer for rotator cuff repair; and Ortho-M, a biopolymer for meniscus repair.
The company was formerly known as Ortho Regenerative Technologies Inc. and changed its name to ChitogenX Inc. in September 2022.
ChitogenX Inc. was incorporated in 2015 and is headquartered in Kirkland, Canada.
ChitogenX Inc.
| Country | Canada |
| Founded | 2015 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Pierre Laurin |
Contact Details
Address: 16667 Hymus Boulevard Kirkland, H9H 4R9 Canada | |
| Phone | 514 261 4735 |
| Website | chitogenx.com |
Stock Details
| Ticker Symbol | CHGX |
| Exchange | Canadian Securities Exchange |
| Share Class | Class A Shares |
| Fiscal Year | February - January |
| Reporting Currency | CAD |
| ISIN Number | CA1699161032 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Pierre Laurin B.Sc.Pharm., M.Sc. | Interim Chief Executive Officer and Chairman |
| Luc Mainville M.B.A. | Senior Vice President and Chief Financial Officer |
| Guy-Paul Allard | Vice President of Legal Affairs and Corporate Secretary |
| Dr. Jonathan Sackier | Senior Vice President of Medical Affairs |
| Frédéric Dumais | Director of Communications and Investor Relations |
| Benedek Simo | Controller |